KORIO

About

Korio is a clinical trial technology company founded in 2021 and based in Doylestown, Pennsylvania. The company specializes in a modern Randomization and Trial Supply Management (RTSM) software platform designed to enhance flexibility, quality, speed, and reliability in managing complex clinical trials. Korio's platform allows trial sponsors to quickly adapt to protocol changes, provides audit trail visibility, and offers responsive expert support. The core RTSM platform includes features for randomization, trial supply management, and drug supply chain optimization. It supports diverse trial designs and therapeutic areas, including oncology and rare diseases, and is built for global operations. Korio also offers mid-study rescue services for vendor transitions and automated supply management solutions. The company has experienced rapid customer adoption and secured Series A funding to support its global expansion and client services.